- $3.71bn
- $3.55bn
- $315.38m
- 85
- 13
- 97
- 71
Annual income statement for Camtek, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 134 | 156 | 270 | 321 | 315 |
| Cost of Revenue | |||||
| Gross Profit | 64.8 | 73.2 | 137 | 160 | 148 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 112 | 133 | 199 | 239 | 250 |
| Operating Profit | 22 | 22.6 | 70.9 | 81.5 | 65.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 22.8 | 23.4 | 71.9 | 88.2 | 87.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 20.8 | 21.8 | 60.3 | 79.9 | 78.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 22 | 21.8 | 60.3 | 79.9 | 78.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 22 | 21.8 | 60.3 | 79.9 | 78.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.542 | 0.539 | 1.34 | 1.66 | 1.63 |
| Dividends per Share |